Skip to main content
. 2011 Nov;55(11):5396–5398. doi: 10.1128/AAC.00679-11

Table 1.

Epidemiological information on Acinetobacter baumannii strainsa

Strain Dates of hospitalization Sex Age (yr) Source of isolate Days of hospitalization Comorbidityb Surgery site(s) Invasive devicesc Treatment Screening CRAd Date of screening CRA
I-15 14/06/2009–01/07/2009 Female 79 Skin 18 CVD Limbs UC, ID Cephalosporins Positive 09/07/2009
I-1 02/07/2009–26/07/2009 Female 84 Skin 24 CVD Limbs, joints UC, ID Cephalosporins Positive 09/07/2009
I-16 08/07/2009–20/08/2009 Female 85 Skin 43 CVD, CLD Limbs, joints UC, ID Cephalosporins Positive 12/07/2009
I-2 09/07/2009–07/08/2009 Female 81 Skin 29 CVD, DM Head-neck UC, ID, Tr No Positive 09/07/2009
I-17 09/07/2009–01/10/2009 Female 75 Skin 84 CVD, DM Limbs, joints UC, ID Cephalosporins Positive 12/07/2009
a

Dates are given as day/month/year.

b

CVD, cardiovascular disease; CLD, chronic lung disease; DM, diabetes mellitus.

c

UC, urinary catheter; ID, intravascular device; Tr, tracheostomy.

d

CRA, carbapenem-resistant Acinetobacter baumannii.